JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Income Before Tax Over TimeExpanding
Percentile Rank93
3Y CAGR+15.9%
5Y CAGR-0.6%
Studio
Year-over-Year Change

Pre-tax earnings

3Y CAGR
+15.9%/yr
vs -7.4%/yr prior
5Y CAGR
-0.6%/yr
Recent acceleration
Acceleration
+23.3pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$9.81B+475.1%
2024$1.71B+513.3%
2023$278.00M-95.6%
2022$6.30B-27.6%
2021$8.71B-14.0%
2020$10.13B+12.1%
2019$9.04B+5.2%
2018$8.59B+16.5%
2017$7.38B+36.0%
2016$5.42B-